Evidence map›Paper›PMID 26909340›Full record

ArticleFrontiers in cellular and infection microbiology2016

Molecular Characterization of a Prevalent Ribocluster of Methicillin-Sensitive Staphylococcus aureus from Orthopedic Implant Infections. Correspondence with MLST CC30.

Lucio Montanaro, Stefano Ravaioli, Werner Ruppitsch, Davide Campoccia, Giampiero Pietrocola, Livia Visai, Pietro Speziale, Franz Allerberger, Carla Renata Arciola

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Methicillin-sensitiveMicrobial genomics · 2025
    Article
  2. Article
  3. Colonization and Infection of Indwelling Medical Devices byInternational journal of molecular sciences · 2022
    Review
  4. Article
  5. Comparison of Automated Ribotyping,International journal of molecular sciences · 2022
    Article
  6. Virulence Determinants inFrontiers in microbiology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Lucio MontanaroResearch Unit on Implant Infections, Rizzoli Orthopaedic InstituteBologna, Italy; Department of Experimental, Diagnostic, and Specialty Medicine, University of BolognaBologna, Italy.
Stefano RavaioliResearch Unit on Implant Infections, Rizzoli Orthopaedic InstituteBologna, Italy; Department of Experimental, Diagnostic, and Specialty Medicine, University of BolognaBologna, Italy.
Werner RuppitschDivision of Human Medicine, Austrian Agency for Health and Food Safety Vienna, Austria.
Davide CampocciaResearch Unit on Implant Infections, Rizzoli Orthopaedic Institute Bologna, Italy.
Giampiero PietrocolaUnit of Biochemistry, Department of Molecular Medicine, University of Pavia Pavia, Italy.
Livia VisaiMolecular Medicine Department, Center for Health Technologies (CHT), UdR INSTM, University of PaviaPavia, Italy; Department of Occupational Medicine, Toxicology and Environmental Risks, S. Maugeri FoundationIRCCS, Pavia, Italy.
Pietro SpezialeUnit of Biochemistry, Department of Molecular Medicine, University of Pavia Pavia, Italy.
Franz AllerbergerDivision of Human Medicine, Austrian Agency for Health and Food Safety Vienna, Austria.
Carla Renata ArciolaResearch Unit on Implant Infections, Rizzoli Orthopaedic InstituteBologna, Italy; Department of Experimental, Diagnostic, and Specialty Medicine, University of BolognaBologna, Italy.
Austrian Agency for Health and Food Safety · ATIstituto Ortopedico Rizzoli · ITUniversity of Bologna · ITUniversity of Pavia · ITFondazione Salvatore Maugeri · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Staphylococcus aureus is the leading etiologic agent of orthopedic implant infections. Here a ribocluster of 27 S. aureus strains underwent further molecular characterization and subtyping by multilocus sequence typing (MLST) and spa-typing. This cluster had been detected by automated ribotyping (with the EcoRI restriction enzyme) of 200 S. aureus isolates from periprosthetic infections of patients who underwent revision at the Rizzoli Orthopaedic Institute. The ribocluster, consisting of agr type III strains, with a 74% co-occurrence of bone sialoprotein-binding (bbp) and collagen-binding (cna) genes, lacked mecA and IS256, and exhibited a high prevalence of the toxic shock syndrome toxin gene (tst, 85%). Strains' relatedness was analyzed by BURP and eBURST. Two predominant spa types, t012 (32%) and t021 (36%), and one predominant sequence type, ST30 (18/27, 67%) were identified: a S. aureus lineage spread worldwide belonging to MLST CC30. Two new sequence types (ST2954, ST2960) and one new spa type (t13129) were detected for the first time. Interestingly, the 27-strain cluster detected by ribotyping corresponded exactly to MLST CC30, the sole CC identified by eBURST.

Indexed as

Adhesins, BacterialAnti-Bacterial AgentsBacterial ProteinsBacterial ToxinsCarrier ProteinsDrug Resistance, BacterialEnterotoxinsHumansMicrobial Sensitivity TestsMultilocus Sequence TypingPenicillin-Binding ProteinsProsthesis-Related InfectionsRibotypingStaphylococcal InfectionsStaphylococcus aureusSuperantigensAdhesins, Bacterialadhesin, Staphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsBacterial Toxinsbone sialoprotein-binding protein, Staphylococcus aureusCarrier Proteinsenterotoxin F, StaphylococcalEnterotoxinsmecA protein, Staphylococcus aureusPenicillin-Binding ProteinsSuperantigensVirulence Factorsmethicillin-sensitive Staphylococcus aureusmultilocus sequence typingorthopedic implant infectionsspa-typingvirulence factors

Identifiers

PMID26909340
PMCPMC4754407
OpenAlexW2276767035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.